Protara Therapeutics, Inc.
USD3.88
-0.28 (-6.61%)
CEO
Jesse Shefferman
IPO Date
2014-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.01
Prev. Close
$4.16
Day Low
$3.79
Day High
$4.01
52W Low
$2.77
52W High
$7.82
Market Cap
$0.15B
Volume
0.66M
| -2.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -59.2% | -51.2% | 0.08 | 11.17 | -0.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -64.6% | -58.2% | 0.06 | 15.01 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -29.2% | -27.4% | 0.04 | 21.66 | -1.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -17.1% | -16.7% | 0.01 | 58.13 | -5.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -234.5% | -214.9% | 0.00 | 11.96 | -4.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -124.4% | -108.1% | 0.00 | 7.55 | -9.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -86.3% | -68.1% | 0.00 | 4.71 | -1.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -74.2% | -65.5% | 0.00 | 8.42 | -1.1 |
| -3.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -10.0% | -9.2% | 0.03 | 13.69 | -3.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.4% | -9.5% | 0.03 | 12.82 | -2.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -7.5% | -7.1% | 0.03 | 18.03 | -3.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.6% | -7.0% | 0.03 | 15.71 | -2.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -13.7% | -11.9% | 0.06 | 9.85 | -0.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -10.3% | -9.4% | 0.05 | 16.33 | -1.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -19.0% | -16.3% | 0.09 | 10.53 | -1.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -15.0% | -12.9% | 0.08 | 11.17 | -0.5 |